Global Fertility Enhancing Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 157615
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Infertility is the major problem worldwide and results in the abnormal functioning of the male or female reproductive system and can manifest as an inability to get pregnant, inability to maintain the pregnancy or inability to maintain the pregnancy to a live birth.

Scope of the Report:

This report studies the Fertility Enhancing Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Fertility Enhancing Treatment market by product type and applications/end industries.

Aging is one of the major problem decreasing women’s fertility. Increased age results to reduced ovulation and miscarriage chances and other health problems after.

United States leads the fertility enhancement treatment market reasons being lifestyle changes, new product innovations, and early treatment adoption. Europe is the second leading market for fertility enhancement treatment market due to development activities and large research base.

The Asia Pacific market is also expected to grow at a higher rate owing to changing lifestyle, large target patient pool, rapid population growth, adoption of western lifestyle, and growth in research and development.

The global Fertility Enhancing Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Fertility Enhancing Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Cooper Surgical

Merck

Vitrolife AB

Monash IVF

Ferring Pharmaceuticals

Halotech DNA

IntegraMed America

Cook

Esco Micro

Genea

Halotech

Ihmedical

Irvine Scientific

Ivftech Aps

Kitazato

Pantarhei Bioscience

Rinovum Women'S Health

Scsa Diagnostics

Thermo Fisher Scientific

Vitrolife

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Fertility Drugs for Women

Fertility Drugs for Men

Market Segment by Applications, can be divided into

Hospital Pharmacy

Drug Stores

Retail Pharmacy

E-commerce 

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Fertility Enhancing Treatment Market Overview

1.1 Product Overview and Scope of Fertility Enhancing Treatment

1.2 Classification of Fertility Enhancing Treatment by Types

1.2.1 Global Fertility Enhancing Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Fertility Enhancing Treatment Revenue Market Share by Types in 2017

1.2.3 Fertility Drugs for Women

1.2.4 Fertility Drugs for Men

1.3 Global Fertility Enhancing Treatment Market by Application

1.3.1 Global Fertility Enhancing Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacy

1.3.3 Drug Stores

1.3.4 Retail Pharmacy

1.3.5 E-commerce 

1.4 Global Fertility Enhancing Treatment Market by Regions

1.4.1 Global Fertility Enhancing Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Fertility Enhancing Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Fertility Enhancing Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Fertility Enhancing Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Fertility Enhancing Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Fertility Enhancing Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Fertility Enhancing Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Cooper Surgical

2.1.1 Business Overview

2.1.2 Fertility Enhancing Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Cooper Surgical Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Fertility Enhancing Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Vitrolife AB

2.3.1 Business Overview

2.3.2 Fertility Enhancing Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Vitrolife AB Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Monash IVF

2.4.1 Business Overview

2.4.2 Fertility Enhancing Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Monash IVF Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Ferring Pharmaceuticals

2.5.1 Business Overview

2.5.2 Fertility Enhancing Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Ferring Pharmaceuticals Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Halotech DNA

2.6.1 Business Overview

2.6.2 Fertility Enhancing Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Halotech DNA Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 IntegraMed America

2.7.1 Business Overview

2.7.2 Fertility Enhancing Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 IntegraMed America Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Cook

2.8.1 Business Overview

2.8.2 Fertility Enhancing Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Cook Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 Esco Micro

2.9.1 Business Overview

2.9.2 Fertility Enhancing Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Esco Micro Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.10 Genea

2.10.1 Business Overview

2.10.2 Fertility Enhancing Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Genea Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.11 Halotech

2.11.1 Business Overview

2.11.2 Fertility Enhancing Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Halotech Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.12 Ihmedical

2.12.1 Business Overview

2.12.2 Fertility Enhancing Treatment Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Ihmedical Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.13 Irvine Scientific

2.13.1 Business Overview

2.13.2 Fertility Enhancing Treatment Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Irvine Scientific Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.14 Ivftech Aps

2.14.1 Business Overview

2.14.2 Fertility Enhancing Treatment Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Ivftech Aps Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.15 Kitazato

2.15.1 Business Overview

2.15.2 Fertility Enhancing Treatment Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Kitazato Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.16 Pantarhei Bioscience

2.16.1 Business Overview

2.16.2 Fertility Enhancing Treatment Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Pantarhei Bioscience Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.17 Rinovum Women'S Health

2.17.1 Business Overview

2.17.2 Fertility Enhancing Treatment Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Rinovum Women'S Health Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.18 Scsa Diagnostics

2.18.1 Business Overview

2.18.2 Fertility Enhancing Treatment Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Scsa Diagnostics Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.19 Thermo Fisher Scientific

2.19.1 Business Overview

2.19.2 Fertility Enhancing Treatment Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Thermo Fisher Scientific Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.20 Vitrolife

2.20.1 Business Overview

2.20.2 Fertility Enhancing Treatment Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Vitrolife Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Fertility Enhancing Treatment Market Competition, by Players

3.1 Global Fertility Enhancing Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Fertility Enhancing Treatment Players Market Share

3.2.2 Top 10 Fertility Enhancing Treatment Players Market Share

3.3 Market Competition Trend

4 Global Fertility Enhancing Treatment Market Size by Regions

4.1 Global Fertility Enhancing Treatment Revenue and Market Share by Regions

4.2 North America Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

5 North America Fertility Enhancing Treatment Revenue by Countries

5.1 North America Fertility Enhancing Treatment Revenue by Countries (2013-2018)

5.2 USA Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

6 Europe Fertility Enhancing Treatment Revenue by Countries

6.1 Europe Fertility Enhancing Treatment Revenue by Countries (2013-2018)

6.2 Germany Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

6.4 France Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Fertility Enhancing Treatment Revenue by Countries

7.1 Asia-Pacific Fertility Enhancing Treatment Revenue by Countries (2013-2018)

7.2 China Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

7.5 India Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

8 South America Fertility Enhancing Treatment Revenue by Countries

8.1 South America Fertility Enhancing Treatment Revenue by Countries (2013-2018)

8.2 Brazil Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Fertility Enhancing Treatment by Countries

9.1 Middle East and Africa Fertility Enhancing Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Fertility Enhancing Treatment Revenue and Growth Rate (2013-2018)

10 Global Fertility Enhancing Treatment Market Segment by Type

10.1 Global Fertility Enhancing Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Fertility Enhancing Treatment Market Forecast by Type (2018-2023)

10.3 Fertility Drugs for Women Revenue Growth Rate (2013-2023)

10.4 Fertility Drugs for Men Revenue Growth Rate (2013-2023)

11 Global Fertility Enhancing Treatment Market Segment by Application

11.1 Global Fertility Enhancing Treatment Revenue Market Share by Application (2013-2018)

11.2 Fertility Enhancing Treatment Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacy Revenue Growth (2013-2018)

11.4 Drug Stores Revenue Growth (2013-2018)

11.5 Retail Pharmacy Revenue Growth (2013-2018)

11.6 E-commerce  Revenue Growth (2013-2018)

12 Global Fertility Enhancing Treatment Market Size Forecast (2018-2023)

12.1 Global Fertility Enhancing Treatment Market Size Forecast (2018-2023)

12.2 Global Fertility Enhancing Treatment Market Forecast by Regions (2018-2023)

12.3 North America Fertility Enhancing Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Fertility Enhancing Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Fertility Enhancing Treatment Revenue Market Forecast (2018-2023)

12.6 South America Fertility Enhancing Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Fertility Enhancing Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Fertility Enhancing Treatment Picture

Table Product Specifications of Fertility Enhancing Treatment

Table Global Fertility Enhancing Treatment and Revenue (Million U

Please fill the form below, to recieve the report sample


+1